Cardiovascular Risk Factor, Physical Activity, Sedentary Lifestyle
Conditions
Brief summary
This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university.
Detailed description
This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. Participants were regular attendees in either a 6am or 12pm exercise program session. Data included both measures of physical health as well as cognitive health. Measures of physical health included the assessment of body fat using the skin-fold method of analysis (3-site). Cholesterol was measured via blood draw analysis. This was done at the Kent State University Exercise Physiology Laboratory by certified research staff. A 6 minute walk test was completed to measure aerobic capacity. Flexibility was assessed via the sit-and-reach test while anaerobic strength and endurance were assessed using sit-up and curl-up tests. Assessment of balance was done using a Biodex Balance System. Assessments of cognitive health included several questionnaires that asked questions related to sleep habits, stress levels, and mood. In addition, each participant was given a MOVband to track physical activity. The device was worn during waking hours for all days of participation.The data from the MOVband was auto-uploaded to a computer program for tracking so that no manual entry was necessary.
Interventions
BEHAVIORALPhysical Activity
Participants underwent 12-weeks of exercise prescription aimed at the federal guidelines (3 days/week).
Sponsors
Kent State University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* age 21-65 years * current faculty/staff member * no contraindications to exercise * sedentary prior to enrollment
Exclusion criteria
* age \<21 years, \>65 years * non faculty/staff member * contraindications to exercise * regular exercise participation prior to enrollment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Impaired Fasting Glucose | Change from baseline impaired fasting glucose at 4-weeks, 8-weeks, and 12-weeks follow-up. | Objectively measured impaired fasting glucose in milligrams per deciliter using a standard assay kit. |
| Height | Assessed once at baseline. | Objectively measured height in meters using a standard clinical stadiometer. |
| Weight | Change from baseline weight at 4-weeks, 8-weeks, and 12-weeks follow-up. | Objectively measured weight in kilograms using a standard clinical scale. |
| Systolic Blood Pressure | Change from baseline systolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up. | Objectively measured systolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer. |
| Diastolic Blood Pressure | Change from baseline diastolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up. | Objectively measured diastolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer. |
| High-Density Lipoprotein | Change from baseline high-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up. | Objectively measured high-density lipoprotein in milligrams per deciliter using a standard assay kit. |
| Low-Density Lipoprotein | Change from baseline low-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up. | Objectively measured low-density lipoprotein in milligrams per deciliter using a standard assay kit. |
| Total Serum Cholesteral | Change from baseline total serum cholesterol at 4-weeks, 8-weeks, and 12-weeks follow-up. | Objectively measured total serum cholesterol in milligrams per deciliter using a standard assay kit. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Accelerometer-Based Physical Activity | Change from baseline accelerometer-based physical activity 4-weeks, 8-weeks, and 12-weeks follow-up using 1-minute epochs. | Assessment of accelerometer-based physical activity outcome measures (e.g., steps per day). |
Other
| Measure | Time frame | Description |
|---|---|---|
| Anxiety (Depression, Anxiety, and Stress Scale-21) | Change from baseline anxiety at 4-weeks, 8-weeks, and 12-weeks follow-up. | The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress. |
| Stress (Depression, Anxiety, and Stress Scale-21) | Change from baseline stress at 4-weeks, 8-weeks, and 12-weeks follow-up. | The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress. |
| Depression (Depression, Anxiety, and Stress Scale-21) | Change from baseline depression at 4-weeks, 8-weeks, and 12-weeks follow-up. | The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress. |
| Quality of Life (36-Item Short Form Survey) | Change from baseline quality of life at 4-weeks, 8-weeks, and 12-weeks follow-up. | The 36-item short form survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. |
| Sleep Quality (Pittsburgh Sleep Quality Index) | Change from baseline sleep quality at 4-weeks, 8-weeks, and 12-weeks follow-up. | The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. |
| Mood (Profile of Mood States) | Change from baseline mood at 4-weeks, 8-weeks, and 12-weeks follow-up. | The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states. |
Outcome results
None listed